News

Amwill Healthcare Limited will hold a meeting of its Board of Directors on Friday, October 23, 2026, to approve the unaudited financial results for the half year ended September 30, 2026, and consider a declaration of an interim dividend to equity shareholders. The company’s trading window for designated persons, relatives, and insiders was closed from October 1, 2026, and will reopen 48 hours after the announcement of the unaudited financial results, as per Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.

AMWILL HEALTH CARE LIMITED submitted a certificate to the BSE Limited, confirming compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the second quarter ended September 30, 2026, as certified by Registrar and Transfer Agent Bigshare Services Private Limited.

Amwill Healthcare Limited informed the Bombay Stock Exchange that the trading window for dealing in the company`s securities will be closed for designated persons, their immediate relatives, and other insiders from October 1, 2026, until 48 hours after the declaration of the un-audited financial results for the half-year ending September 30, 2026, in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.

Amwill Health Care Limited informed the Bombay Stock Exchange that its members approved the re-appointment of Tarun Gandhi and Anand Gandhi as Managing Directors and Key Managerial Personnel for a further term of five years, effective January 27, 2027, until January 26, 2032.

Amwill Health Care announced that the 9th Annual General Meeting(AGM) of the company will be held on 14 August 2026.